129 related articles for article (PubMed ID: 37749047)
1. [A case of Hb M-Iwate combined with diffuse large B-cell lymphoma].
Ye SW; Shen KF; Xiao M; Zhang PL; Zhang SY; Deng T; Huang L; Zhou XX
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):607. PubMed ID: 37749047
[No Abstract] [Full Text] [Related]
2. Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study.
Tilly H; Morschhauser F; Bartlett NL; Mehta A; Salles G; Haioun C; Munoz J; Chen AI; Kolibaba K; Lu D; Yan M; Penuel E; Hirata J; Lee C; Sharman JP
Lancet Oncol; 2019 Jul; 20(7):998-1010. PubMed ID: 31101489
[TBL] [Abstract][Full Text] [Related]
3. Resonance raman studies of hemoglobins M: evidence for iron-tyrosine charge-transfer interactions in the abnormal subunits of Hb M Boston and Hb M Iwate.
Nagai K; Kagimoto T; Hayashi A; Taketa F; Kitagawa T
Biochemistry; 1983 Mar; 22(5):1305-11. PubMed ID: 6838855
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
5. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.
Nakayama S; Matsuda M; Adachi T; Sueda S; Ohashi Y; Awaji S; Hashimoto S; Matsumura I
Platelets; 2019; 30(5):637-645. PubMed ID: 30047815
[TBL] [Abstract][Full Text] [Related]
6. A case of primary adrenal diffuse large B-cell lymphoma in HIV.
Malik S; Chapman CB; Drew O
Int J STD AIDS; 2016 Jul; 27(8):687-9. PubMed ID: 26113518
[TBL] [Abstract][Full Text] [Related]
7. Consolidation anti-CD22 fractionated radioimmunotherapy with
Kraeber-Bodere F; Pallardy A; Maisonneuve H; Campion L; Moreau A; Soubeyran I; Le Gouill S; Tournilhac O; Daguindau E; Jardel H; Morineau N; Bouabdallah K; Gyan E; Moles MP; Gressin R; Berthou C; Sadot S; Moreau P; Deau B; Bodet-Milin C; Cazeau AL; Garin E; Salaun PY; Vuillez JP; Gouilleux-Gruart V; Barbet J; Wegener WA; Goldenberg DM; Lamy T; Soubeyran P
Lancet Haematol; 2017 Jan; 4(1):e35-e45. PubMed ID: 27964867
[TBL] [Abstract][Full Text] [Related]
8. Primary Diffuse Large B-cell Lymphoma involving the Mandible.
Alshahrani FA; Aljabab AS; Motabi IH; Alrashed A; Anil S
J Contemp Dent Pract; 2015 Oct; 16(10):840-4. PubMed ID: 26581467
[TBL] [Abstract][Full Text] [Related]
9. Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren's syndrome and rheumatoid arthritis: a case report.
Gorodetskiy VR; Probatova NA; Konovalov DM; Ryzhikova NV; Sidorova YV; Sudarikov AB; Mukhortova OV
J Med Case Rep; 2020 Jan; 14(1):12. PubMed ID: 31948469
[TBL] [Abstract][Full Text] [Related]
10. Primary diffuse large B-cell lymphoma of the uterus: case report and review.
Mandato VD; Palermo R; Falbo A; Capodanno I; Capodanno F; Gelli MC; Aguzzoli L; Abrate M; La Sala GB
Anticancer Res; 2014 Aug; 34(8):4377-90. PubMed ID: 25075075
[TBL] [Abstract][Full Text] [Related]
11. Heme structure of hemoglobin M Iwate [alpha 87(F8)His-->Tyr]: a UV and visible resonance Raman study.
Nagai M; Aki M; Li R; Jin Y; Sakai H; Nagatomo S; Kitagawa T
Biochemistry; 2000 Oct; 39(43):13093-105. PubMed ID: 11052661
[TBL] [Abstract][Full Text] [Related]
12. My treatment approach to patients with diffuse large B-cell lymphoma.
Armitage JO
Mayo Clin Proc; 2012 Feb; 87(2):161-71. PubMed ID: 22305028
[TBL] [Abstract][Full Text] [Related]
13. A case of primary adrenal diffuse large B-cell lymphoma achieving complete remission with rituximab-CHOP chemotherapy.
Kim KM; Yoon DH; Lee SG; Lim SN; Sug LJ; Huh J; Suh C
J Korean Med Sci; 2009 Jun; 24(3):525-8. PubMed ID: 19543522
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous Dissemination from an Orbital Diffuse Large B Cell Lymphoma.
Bains S; Vidhya N; Kim U; Shanti R; Devanand J
Orbit; 2015; 34(6):338-9. PubMed ID: 26452055
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
16. A case of a newborn infant with Hb M Iwate.
Kumagai R; Niitsu H; Katsura I; Nakayashiki N; Katsura S
Tohoku J Exp Med; 1986 Nov; 150(3):337-43. PubMed ID: 3824377
[TBL] [Abstract][Full Text] [Related]
17. Clear cell variant of diffuse large B-cell lymphoma: a case report and review of the literature.
Xue Y; Wang Q; He X
Int J Clin Exp Pathol; 2015; 8(6):7594-9. PubMed ID: 26261675
[TBL] [Abstract][Full Text] [Related]
18. NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
Cai Q; Tu M; Xu-Monette ZY; Sun R; Manyam GC; Xu X; Tzankov A; Hsi ED; Møller MB; Medeiros LJ; Ok CY; Young KH
Mod Pathol; 2017 Jun; 30(6):854-876. PubMed ID: 28281555
[TBL] [Abstract][Full Text] [Related]
19. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
Ye Q; Xu-Monette ZY; Tzankov A; Deng L; Wang X; Manyam GC; Visco C; Montes-Moreno S; Zhang L; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; Medeiros LJ; Hu S; Young KH
Oncotarget; 2016 Jan; 7(3):2401-16. PubMed ID: 26573234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
